PL3493823T3 - Składnik na bazie postbiotyki do leczenia zapalenia oka - Google Patents

Składnik na bazie postbiotyki do leczenia zapalenia oka

Info

Publication number
PL3493823T3
PL3493823T3 PL17752060.8T PL17752060T PL3493823T3 PL 3493823 T3 PL3493823 T3 PL 3493823T3 PL 17752060 T PL17752060 T PL 17752060T PL 3493823 T3 PL3493823 T3 PL 3493823T3
Authority
PL
Poland
Prior art keywords
postbiotic
treatment
based composition
ocular inflammation
ocular
Prior art date
Application number
PL17752060.8T
Other languages
English (en)
Other versions
PL3493823T4 (pl
Inventor
Maria Rescigno
Giuseppe Penna
Original Assignee
Istituto Europeo Di Oncologia S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto Europeo Di Oncologia S.R.L. filed Critical Istituto Europeo Di Oncologia S.R.L.
Publication of PL3493823T3 publication Critical patent/PL3493823T3/pl
Publication of PL3493823T4 publication Critical patent/PL3493823T4/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PL17752060.8T 2016-08-03 2017-08-03 Składnik na bazie postbiotyki do leczenia zapalenia oka PL3493823T4 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT102016000081929A IT201600081929A1 (it) 2016-08-03 2016-08-03 Uso del surnatante di lactobacillus paracasei nel trattamento della congiuntivite, in particolare della vernal cheratocongiuntivite
PCT/EP2017/069681 WO2018024833A1 (en) 2016-08-03 2017-08-03 Postbiotic-based composition for treatment of ocular inflammation

Publications (2)

Publication Number Publication Date
PL3493823T3 true PL3493823T3 (pl) 2025-08-11
PL3493823T4 PL3493823T4 (pl) 2025-08-11

Family

ID=57610295

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17752060.8T PL3493823T4 (pl) 2016-08-03 2017-08-03 Składnik na bazie postbiotyki do leczenia zapalenia oka

Country Status (7)

Country Link
US (1) US20190175670A1 (pl)
EP (1) EP3493823B1 (pl)
CA (1) CA3031379A1 (pl)
ES (1) ES3018261T3 (pl)
IT (1) IT201600081929A1 (pl)
PL (1) PL3493823T4 (pl)
WO (1) WO2018024833A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6640803B2 (ja) 2016-09-09 2020-02-05 キリンホールディングス株式会社 眼疲労の抑制又は改善用組成物
US12161681B2 (en) 2018-02-02 2024-12-10 Postbiotica S.R.L. Postbiotic-based composition for the modulation of immune system activation and protection of mucosal barriers
WO2019149940A1 (en) * 2018-02-02 2019-08-08 Postbiotica S.R.L. Use of a postbiotic-based composition for the treatment of skin diseases
IT201900023142A1 (it) * 2019-12-05 2021-06-05 Sifi Spa Composizione topica oculare contenente metaboliti della fermentazione di lactobacillus
CN111944725B (zh) * 2020-08-24 2021-12-07 汤臣倍健股份有限公司 一种副干酪乳杆菌207-27及其应用
WO2025023853A1 (en) 2023-07-27 2025-01-30 Universitatea "Dunărea De Jos" Din Galaţi Obtaining processes for some metabiotic ingredients with bioactive properties based on bovine colostrum and potentially probiotic lactic acid bacteria belonging to lactiplantibacillus spp

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20060237A1 (it) * 2006-05-03 2007-11-04 Anabasis S R L Uso dei probiotici nella prevenzione e nel trattamento delle congiuntiviti allergiche
MX2009006810A (es) * 2006-12-22 2009-11-23 Francois-Marie Luquet Inhibicion del crecimiento de microorganismos por bacterias del acido lactico.
US20120087902A1 (en) * 2009-07-20 2012-04-12 Bracco S.P.A. Therapeutic Use Of Probiotics
AU2012273206B2 (en) * 2011-06-20 2015-09-24 H.J. Heinz Company Brands Llc Probiotic compositions and methods

Also Published As

Publication number Publication date
US20190175670A1 (en) 2019-06-13
WO2018024833A1 (en) 2018-02-08
IT201600081929A1 (it) 2018-02-03
PL3493823T4 (pl) 2025-08-11
ES3018261T3 (en) 2025-05-14
EP3493823C0 (en) 2024-12-25
CA3031379A1 (en) 2018-02-08
EP3493823A1 (en) 2019-06-12
EP3493823B1 (en) 2024-12-25

Similar Documents

Publication Publication Date Title
IL246791A0 (en) Compositions and methods for treating eye diseases
EP3177732A4 (en) Compositions and methods for the treatment of ophthalmic diseases and conditions
EP3463315C0 (en) COMPOSITIONS AND METHODS OF USE OF NINTEDANIB FOR THE TREATMENT OF ABNORMAL NEOVASCULARIZATION OCULAR DISEASES
IL258032A (en) Compounds and preparations for the treatment of ocular disorders
IL270752B (en) Pyrrolopyridine-aniline compounds for the treatment of skin disorders
PL3493823T3 (pl) Składnik na bazie postbiotyki do leczenia zapalenia oka
IL290069A (en) Methods for treating eye conditions
EP3253211A4 (en) Compositions and methods for treatment of edema
GB2541840B (en) Ophthalmic composition for the treatment of ocular infection
WO2016094899A3 (en) Treatment of hmgb1-mediated inflammation
GB201612043D0 (en) Composition for treatment of disorders
SG11201705524SA (en) Compositions and methods for the treatment of inflammation and pain
EP3107534A4 (en) Compositions and methods for the treatment of neurodegenerative diseases
SG11201809811VA (en) Compositions and methods for treatment of inflammation or infection of the eye
IL270362B (en) Glaucoma treatment
EP3265103A4 (en) Compositions and methods for treating ocular diseases
EP3302382A4 (en) IMPLANT FOR THE TREATMENT OF OCULAR DISEASE
HUE062406T2 (hu) Készítmények szemészeti állapotok kezelésére
EP3271017A4 (en) Treatment of skin conditions
EP3280406A4 (en) COMPOSITIONS AND METHODS FOR TREATING MOVEMENT DISORDERS
IL263336B (en) Compounds for the treatment of symphysiolysis
PL3164110T3 (pl) Kompozycje farmaceutyczne do leczenia łuszczycy
EP3129054A4 (en) Methods and compositions for the treatment of ocular diseases and disorders
SG10201913141UA (en) Treatment of alphavirus-induced inflammation
GB201816914D0 (en) Treatment of inflammation